The 1st Nordic conference on personalized medicine will take place from May 30th – June 1st 2018 at Hotel Nyborg Strand in Nyborg Denmark.This 3-day conference will focus on both basic and clinical aspects of research regarding personalized medicine. The program will consist of talks and workshops within pharmacogenetics, drug interactions, epigenetics and other factors that may cause variation in drug response among individuals. Furthermore, there will be focus on methods available across the participating researchers.
Talks from high profile academic and clinical experts; senior government and industry representatives; and a patient representative will highlight how the UK is leading the way in pharmacogenetics and stratified medicine. This event provides a great opportunity to meet with colleagues from across all sectors involved in delivering personalised medicine to patients.
3rd International Transporter Consortium Workshop at ASCPT | March 13-14 2017 | Membrane Transporters in Drug Development
Contextualized 3D molecular illustration using ePMV to depict the title– Promiscuous membrane drug transporters provide novel pharmaceutical targets, as used on the cover of the journal Clinical Pharmacology and Therapeutics. Used with permission from the artist, Graham Johnson ©2009.
The International Transporter Consortium (ITC) will host its 3rd workshop focusing on new research in membrane transporters, particularly as they relate to drug development. This workshop will take place immediately before the ASCPT 2017 Annual Meeting, March 13-14, 2017, at the Omni Shoreham Hotel in Washington, DC.
The 3rd Workshop on Membrane Transporters in Drug Development is a two-day workshop, with speakers who are prominent transporter biologists from universities, regulatory agencies and pharmaceutical companies. The workshop will cover a range of topics in transporter biology, including the endogenous function of transporters, emerging transporters of importance in drug development, modeling of transporters, genomics and biomarker probes of transporters, as well as regulatory issues in transporter-mediated drug-drug interactions. Case studies representing perspectives of regulatory agencies (e.g., FDA and EMA) will be presented along with a panel discussion involving experts in the field to address questions from the attendees. Finally, there will be breakout groups of interested scientists who will focus on writing whitepapers, review articles and commentary to be published in a special issue of Clinical Pharmacology & Therapeutics.
Please visit the link for more information about the meeting agenda and registration (Don’t miss the huge discount for trainee/student member!).